Scholarlink

<p>Cortisol/corticosterone (CORT) are typical glucocorticoids and exert an anti-stress function. p27, a cyclin-dependent kinase inhibitor, acts as a terminal factor for Sertoli cell proliferation at the prepubescent stage. Our previous study showed neonatal CORT administration increased p27-positive Sertoli cells followed by decreasing Sertoli cells in mice. The present study evaluated the effects of CORT and/or RU 486, a glucocorticoid receptor antagonist, on Sertoli cells in early life stages. CORT and/or RU 486 were subcutaneously injected to ICR mice, from postnatal days (PNDs) 1 to 10, at doses of 0.36 and 0.0006&#xa0;mg/kg body weight, respectively. Testes from control, CORT-, RU 486 + CORT-, and RU 486-administered mice were evaluated on PNDs 4, 10, and 16. RU 486 administration blocked CORT-induced increase of relative p27-positive Sertoli cells, with the resultant recovery of Sertoli cell numbers to control level. RU 486 administration alone unexpectedly caused decreases in Sertoli cells. The present study is the first to reveal that activation of glucocorticoid receptors following CORT administration in early life stages is involved in p27-positive Sertoli cell and total Sertoli cell number in vivo, suggesting that appropriate glucocorticoid signaling in early life stages is required for the intact proliferation and maturation of Sertoli cells.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

RU 486 blocks inhibitory effect of neonatal corticosterone administration on sertoli cell proliferation in mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月23日

查看全文
  • Hidenobu Miyaso,
  • Yutaro Natsuyama,
  • Shinichi Kawata,
  • Tomiko Yakura,
  • Zhong-Lian Li,
  • Miyuki Kuramasu,
  • Shota Tanifuji,
  • Xi Wu,
  • Yuki Ogawa,
  • Yoshiharu Matsuno,
  • Masahiro Itoh

摘要

Cortisol/corticosterone (CORT) are typical glucocorticoids and exert an anti-stress function. p27, a cyclin-dependent kinase inhibitor, acts as a terminal factor for Sertoli cell proliferation at the prepubescent stage. Our previous study showed neonatal CORT administration increased p27-positive Sertoli cells followed by decreasing Sertoli cells in mice. The present study evaluated the effects of CORT and/or RU 486, a glucocorticoid receptor antagonist, on Sertoli cells in early life stages. CORT and/or RU 486 were subcutaneously injected to ICR mice, from postnatal days (PNDs) 1 to 10, at doses of 0.36 and 0.0006 mg/kg body weight, respectively. Testes from control, CORT-, RU 486 + CORT-, and RU 486-administered mice were evaluated on PNDs 4, 10, and 16. RU 486 administration blocked CORT-induced increase of relative p27-positive Sertoli cells, with the resultant recovery of Sertoli cell numbers to control level. RU 486 administration alone unexpectedly caused decreases in Sertoli cells. The present study is the first to reveal that activation of glucocorticoid receptors following CORT administration in early life stages is involved in p27-positive Sertoli cell and total Sertoli cell number in vivo, suggesting that appropriate glucocorticoid signaling in early life stages is required for the intact proliferation and maturation of Sertoli cells.